Our company has been relying on strong research and development capability since 1999. And we have developing a quality cyclodextrin derivative, hydroxypropyI betadex CAS:128446-35-5; betadex suIfobutyl ether sodium CAS:182410-00-0.
Year of Establishment:
1999
Total Number of Staff:
10-50
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: